Company Filing History:
Years Active: 1998
Title: Gizella Toth Nee Gyarmati: Innovator in Pharmaceutical Aerosol Preparations
Introduction
Gizella Toth Nee Gyarmati is a notable inventor from Ullo, Hungary, recognized for her contributions to the field of pharmaceuticals. She has developed an innovative aerosol preparation that offers effective treatment options for asthma patients. Her work exemplifies the intersection of science and healthcare, aiming to improve the quality of life for individuals suffering from respiratory conditions.
Latest Patents
Gizella holds a patent for an antiasthmatic aerosol preparation of sodium cromoglycate. This pharmaceutical composition is designed for inhalation, ensuring effective treatment of the lungs. The aerosol preparation comprises a stabilized suspension of sodium cromoglycate, which is favorably absorbed in the lungs after inhalation. Specifically, the preparation contains 1 to 4% by mass of sodium cromoglycate suspended in a mixture of propellants, along with 0.3 to 2.0% by mass of a dispersing agent consisting of oleyl oleate. This innovative formulation represents a significant advancement in asthma treatment.
Career Highlights
Gizella has made significant strides in her career, particularly through her work at Egis Gyogyszergyar, a leading pharmaceutical company in Hungary. Her dedication to research and development has led to the creation of effective pharmaceutical solutions that address critical health issues. With her expertise, she has contributed to the advancement of inhalation therapies, making a positive impact on patient care.
Collaborations
Gizella has collaborated with several talented individuals in her field, including Margit Nagy and Lidia Fedina. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, ultimately leading to the development of groundbreaking pharmaceutical products.
Conclusion
Gizella Toth Nee Gyarmati's work in developing an antiasthmatic aerosol preparation highlights her commitment to improving respiratory health through innovative pharmaceutical solutions. Her contributions to the field are invaluable, and her patent serves as a testament to her expertise and dedication.